Literature DB >> 29150432

The IKK-related kinase TBK1 activates mTORC1 directly in response to growth factors and innate immune agonists.

Cagri Bodur1, Dubek Kazyken1, Kezhen Huang1, Bilgen Ekim Ustunel1, Kate A Siroky1, Aaron Seth Tooley1, Ian E Gonzalez1, Daniel H Foley1, Hugo A Acosta-Jaquez1, Tammy M Barnes2, Gabrielle K Steinl2, Kae-Won Cho3, Carey N Lumeng3, Steven M Riddle4, Martin G Myers2, Diane C Fingar5.   

Abstract

The innate immune kinase TBK1 initiates inflammatory responses to combat infectious pathogens by driving production of type I interferons. TBK1 also controls metabolic processes and promotes oncogene-induced cell proliferation and survival. Here, we demonstrate that TBK1 activates mTOR complex 1 (mTORC1) directly. In cultured cells, TBK1 associates with and activates mTORC1 through site-specific mTOR phosphorylation (on S2159) in response to certain growth factor receptors (i.e., EGF-receptor but not insulin receptor) and pathogen recognition receptors (PRRs) (i.e., TLR3; TLR4), revealing a stimulus-selective role for TBK1 in mTORC1 regulation. By studying cultured macrophages and those isolated from genome edited mTOR S2159A knock-in mice, we show that mTOR S2159 phosphorylation promotes mTORC1 signaling, IRF3 nuclear translocation, and IFN-β production. These data demonstrate a direct mechanistic link between TBK1 and mTORC1 function as well as physiologic significance of the TBK1-mTORC1 axis in control of innate immune function. These data unveil TBK1 as a direct mTORC1 activator and suggest unanticipated roles for mTORC1 downstream of TBK1 in control of innate immunity, tumorigenesis, and disorders linked to chronic inflammation.
© 2017 The Authors.

Entities:  

Keywords:  IFN‐β; TBK1; mTOR; mTORC1

Mesh:

Substances:

Year:  2017        PMID: 29150432      PMCID: PMC5753041          DOI: 10.15252/embj.201696164

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  91 in total

Review 1.  mTOR signaling in growth control and disease.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Cell       Date:  2012-04-13       Impact factor: 41.582

2.  Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.

Authors:  Emilie Vander Haar; Seong-Il Lee; Sricharan Bandhakavi; Timothy J Griffin; Do-Hyung Kim
Journal:  Nat Cell Biol       Date:  2007-02-04       Impact factor: 28.824

Review 3.  Regulation of mTORC1 by PI3K signaling.

Authors:  Christian C Dibble; Lewis C Cantley
Journal:  Trends Cell Biol       Date:  2015-07-06       Impact factor: 20.808

Review 4.  mTOR in aging, metabolism, and cancer.

Authors:  Marion Cornu; Verena Albert; Michael N Hall
Journal:  Curr Opin Genet Dev       Date:  2013-01-11       Impact factor: 5.578

5.  IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation.

Authors:  Xiaoduo Xie; Denghong Zhang; Bin Zhao; Min-Kan Lu; Ming You; Gianluigi Condorelli; Cun-Yu Wang; Kun-Liang Guan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-04       Impact factor: 11.205

6.  Translational control of the innate immune response through IRF-7.

Authors:  Rodney Colina; Mauro Costa-Mattioli; Ryan J O Dowling; Maritza Jaramillo; Lee-Hwa Tai; Caroline J Breitbach; Yvan Martineau; Ola Larsson; Liwei Rong; Yuri V Svitkin; Andrew P Makrigiannis; John C Bell; Nahum Sonenberg
Journal:  Nature       Date:  2008-02-13       Impact factor: 49.962

Review 7.  Inflammation as a driver and vulnerability of KRAS mediated oncogenesis.

Authors:  Shunsuke Kitajima; Rohit Thummalapalli; David A Barbie
Journal:  Semin Cell Dev Biol       Date:  2016-06-11       Impact factor: 7.727

8.  Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity.

Authors:  Benjamin R tenOever; Sonia Sharma; Wen Zou; Qiang Sun; Nathalie Grandvaux; Ilkka Julkunen; Hiroaki Hemmi; M Yamamoto; Shizuo Akira; Wen-Chen Yeh; Rongtuan Lin; John Hiscott
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway.

Authors:  Brendan D Manning; Andrew R Tee; M Nicole Logsdon; John Blenis; Lewis C Cantley
Journal:  Mol Cell       Date:  2002-07       Impact factor: 17.970

10.  Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue.

Authors:  R Stan; M M McLaughlin; R Cafferkey; R K Johnson; M Rosenberg; G P Livi
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

View more
  30 in total

1.  The IKK-related kinase TBK1 activates mTORC1 directly in response to growth factors and innate immune agonists.

Authors:  Cagri Bodur; Dubek Kazyken; Kezhen Huang; Bilgen Ekim Ustunel; Kate A Siroky; Aaron Seth Tooley; Ian E Gonzalez; Daniel H Foley; Hugo A Acosta-Jaquez; Tammy M Barnes; Gabrielle K Steinl; Kae-Won Cho; Carey N Lumeng; Steven M Riddle; Martin G Myers; Diane C Fingar
Journal:  EMBO J       Date:  2017-11-17       Impact factor: 11.598

2.  Lipotoxicity-induced STING1 activation stimulates MTORC1 and restricts hepatic lipophagy.

Authors:  Kunpeng Liu; Dongbo Qiu; Xue Liang; Yingqi Huang; Yao Wang; Xin Jia; Kun Li; Jingyuan Zhao; Cong Du; Xiusheng Qiu; Jun Cui; Zhendong Xiao; Yunfei Qin; Qi Zhang
Journal:  Autophagy       Date:  2021-08-12       Impact factor: 13.391

Review 3.  Targeting TANK-binding kinase 1 (TBK1) in cancer.

Authors:  Or-Yam Revach; Shuming Liu; Russell W Jenkins
Journal:  Expert Opin Ther Targets       Date:  2020-10-05       Impact factor: 6.902

4.  Activation of STING inhibits cervical cancer tumor growth through enhancing the anti-tumor immune response.

Authors:  Fan Shi; Jin Su; Juan Wang; Zi Liu; Tao Wang
Journal:  Mol Cell Biochem       Date:  2020-11-03       Impact factor: 3.396

5.  Inflammation Triggers Liver X Receptor-Dependent Lipogenesis.

Authors:  Sophie R Liebergall; Jerry Angdisen; Shun Hang Chan; YingJu Chang; Timothy F Osborne; Alexander F Koeppel; Stephen D Turner; Ira G Schulman
Journal:  Mol Cell Biol       Date:  2020-01-03       Impact factor: 4.272

Review 6.  The Race between Host Antiviral Innate Immunity and the Immune Evasion Strategies of Herpes Simplex Virus 1.

Authors:  Huifang Zhu; Chunfu Zheng
Journal:  Microbiol Mol Biol Rev       Date:  2020-09-30       Impact factor: 11.056

Review 7.  Cellular and physiological functions of C9ORF72 and implications for ALS/FTD.

Authors:  Weilun Pang; Fenghua Hu
Journal:  J Neurochem       Date:  2020-12-18       Impact factor: 5.372

8.  Genotoxic stress in constitutive trisomies induces autophagy and the innate immune response via the cGAS-STING pathway.

Authors:  Maria Krivega; Clara M Stiefel; Sahar Karbassi; Line L Andersen; Narendra K Chunduri; Neysan Donnelly; Andreas Pichlmair; Zuzana Storchová
Journal:  Commun Biol       Date:  2021-07-02

Review 9.  How Lysosomes Sense, Integrate, and Cope with Stress.

Authors:  Paul Saftig; Rosa Puertollano
Journal:  Trends Biochem Sci       Date:  2020-10-01       Impact factor: 13.807

10.  Associations of individual and joint expressions of ERCC6 and ERCC8 with clinicopathological parameters and prognosis of gastric cancer.

Authors:  Jing Chen; Liang Li; Liping Sun; Yuan Yuan; Jingjing Jing
Journal:  PeerJ       Date:  2021-07-15       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.